| COGENT (COlorectal cancer GENeTics) revisited. | |
| | |
MedLine Citation:
|
PMID: 22294761 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Many colorectal cancers (CRCs) develop in genetically susceptible individuals most of whom are not carriers of germ line mismatch repair or APC gene mutations and much of the heritable risk of CRC appears to be attributable to the co-inheritance of multiple low-risk variants. The accumulated experience to date in identifying this class of susceptibility allele has highlighted the need to conduct statistically and methodologically rigorous studies and the need for the multi-centre collaboration. This has been the motivation for establishing the COGENT (COlorectal cancer GENeTics) consortium which now includes over 20 research groups in Europe, Australia, the Americas, China and Japan actively working on CRC genetics. Here, we review the rationale for identifying low-penetrance variants for CRC and the current and future challenges for COGENT. |
| | |
Authors:
|
Richard S Houlston; |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Mutagenesis Volume: 27 ISSN: 1464-3804 ISO Abbreviation: Mutagenesis Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-02-01 Completed Date: 2012-05-17 Revised Date: 2013-05-20 |
Medline Journal Info:
|
Nlm Unique ID: 8707812 Medline TA: Mutagenesis Country: England |
Other Details:
|
Languages: eng Pagination: 143-51 Citation Subset: IM |
Affiliation:
|
Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK. richard.houlston@icr.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Colorectal Neoplasms
/
diagnosis,
genetics* Genes, Neoplasm* Genetic Predisposition to Disease* Humans Polymorphism, Genetic / genetics* |
| Grant Support | |
ID/Acronym/Agency:
|
06113/C/04/Z)//Wellcome Trust; //Canadian Institutes of Health Research; //Cancer Research UK |
| Investigator | |
Investigator/Affiliation:
|
Lauri A Aaltonen / ; Hermann Brenner / ; Stephan Buch / ; Harry Campbell / ; Angel Carracedo / ; Luis Carvajal-Carmona / ; Antoni Castells / ; Sergi Castellví-Bel / ; Jeremy P Cheadle / ; Peter Devilee / ; Malcolm Dunlop / ; Magdalena M Echeverry / ; Steven Gallinger / ; Antonella Galvan / ; Jochen Hampe / ; Kari Hemminki / ; Judy W C Ho / ; Robert M W Hofstra / ; Tom J Hudson / ; Iva Kirac / ; Markus M Lerch / ; Li Li / ; Annika Lindblom / ; Lara Lipton / ; Koichi Matsuda / ; Timothy S Maughan / ; Victor Moreno / ; Hans Morreau / ; Alessio Naccarati / ; Yusuke Nakamura / ; Paolo Peterlongo / ; Paul D Pharoah / ; Oliver Sieber / ; Paolo Radice / ; Clara Ruiz-Ponte / ; Clemens Schafmayer / ; Christian A Schmidt / ; Witigo von Schönfels / ; Stefan Schreiber / ; Rodney Scott / ; Pak Sham / ; Pavel Soucek / ; Albert Tenesa / ; Ian P M Tomlinson / ; Alejandro Velez / ; Cristna M Villanueva / ; Pavel Vodicka / ; Henry Vo lzke / ; Tom van Wezel / ; Juul T Wijnen / ; Brent Zanke / |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Val...
Next Document: Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience.